» Articles » PMID: 25771465

Seroprevalence of Hepatitis Viruses and Risk Factors in Blood Donors of Veracruz, Mexico

Overview
Date 2015 Mar 16
PMID 25771465
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hepatitis B and C are among the most important transfusion-transmitted infections and sources of liver diseases worldwide. In Veracruz, Mexico, liver diseases are important causes of mortality, and the prevalence reports of these viruses are scarce. This study sought to determine the prevalence of these infections in blood donors, in order to increase the safety of blood products in this region.

Methodology: A retrospective study was performed on blood donors who attended the Veracruz State Blood Transfusion Center from 2006 to 2010. All samples were screened for transfusion-transmitted infections. The prevalence rates of hepatitis B virus (HBV) and hepatitis C virus (HCV) were determined, and demographic data obtained from clinical records were used to evaluate risk factors.

Results: A total of 56,377 donors were serologically screened; of them, 403 were seropositive for HCV (357 men and 46 women), and 61 were positive for HBsAg (52 men and 9 women). The overall prevalence rates were 0.72% (0.63%-0.76%) for HCV and 0.11% (0.08%-0.14%) for HBsAg. The risk factors for HBsAg positivity were being a cattleman and living in the Huasteca Baja region, whereas those for HCV were being a fisherman, living in the Papaloapan region, and having an elementary-level or lower education.

Conclusions: This is the first study to show that being a fisherman is a risk factor for HCV. The implementation of nucleic acid test technology will help to identify the real risks for transfusion-transmitted hepatitis C in Veracruz.

Citing Articles

An Update on Viral Hepatitis B and C in Mexico: Advances and Pitfalls in Eradication Strategies.

Campos-Valdez M, Castro-Garcia M, Ramos-Marquez M, Gurrola-Diaz C, Salazar-Montes A, Sanchez-Orozco L Microorganisms. 2024; 12(7).

PMID: 39065136 PMC: 11279215. DOI: 10.3390/microorganisms12071368.


Assessment of prevalence and risk factors associated with Hepatitis B virus infection among blood donors in Mogadishu Somalia.

Mohamud A, Inchon P, Suwannaporn S, Prasert K, Dirie N BMC Public Health. 2024; 24(1):690.

PMID: 38438851 PMC: 10913210. DOI: 10.1186/s12889-024-18136-2.


Hepatitis B Virus Genotype H: Epidemiological, Molecular, and Clinical Characteristics in Mexico.

Panduro A, Roman S, Laguna-Meraz S, Jose-Abrego A Viruses. 2023; 15(11).

PMID: 38005864 PMC: 10675821. DOI: 10.3390/v15112186.


Intravenous versus topical tranexamic acid in lumbar interbody fusion: A protocol of randomized controlled trial.

Song F, Zheng Z Medicine (Baltimore). 2020; 99(24):e20619.

PMID: 32541498 PMC: 7302681. DOI: 10.1097/MD.0000000000020619.


Hepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) results.

Lopez-Gatell H, Garcia-Garcia L, Echaniz-Aviles G, Cruz-Hervert P, Olamendi-Portugal M, Castaneda-Desales D Hum Vaccin Immunother. 2018; 15(2):433-439.

PMID: 30380981 PMC: 6422518. DOI: 10.1080/21645515.2018.1533617.